Stada is postponing its initial public offering in Germany, the latest IPO candidate to put plans to go public on hold after U.S. President Trump’s tariff blitz rattled markets globally. The ...

(Bloomberg) -- Stada Arzneimittel AG’s private equity owners are pushing back a planned initial public offering of the German drugmaker until September, people with knowledge of the matter said.

FRANKFURT (Reuters) -German pharma firm Stada plans to launch its initial public offering (IPO) as soon as Wednesday, two people familiar with the matter said, in a test for Europe's equity markets.

Stada will postpone its planned initial public listing on the Frankfurt stock exchange as a result of U.S. tariffs, market volatility and geopolitical uncertainties. The German healthcare company ...

FRANKFURT, March 18 (Reuters) - German pharmaceuticals company Stada has postponed a planned initial public offering (IPO) in Frankfurt because of market volatility, two people familiar with the ...

German drugmaker Stada Arzneimittel's private-equity owners Bain Capital and Cinven are delaying a planned initial public offering of the company until September due to recent market uncertainties ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...